Vir Biotechnology Inc

NASDAQ:VIR   3:59:50 PM EDT
26.64
+1.80 (+7.25%)
Products

Vir Biotechnology And Wuxi Bio Entered Into A Termination Agreement

Published: 05/20/2022 21:27 GMT
Vir Biotechnology Inc (VIR) - Vir Biotechnology Inc - on May 16, Company and Wuxi Bio Entered Into a Termination Agreement.
Vir Biotechnology Inc - Under Termination Agreement, All Licenses Granted Under Wuxi Collaboration Agreement Are Terminated.
Vir Biotechnology Inc - Under Termination Agreement, All Rights to Vir Antibodies in Greater China Are Reverted to Company.
Vir Biotechnology Inc - Will Make a One-time Payment to Wuxi Bio of $7 Million for Wuxi Bio's Development Activities Under Wuxi Collaboration Agreement.
Vir Biotechnology - Obligated to Pay Wuxi Bio Tiered Royalties on Net Sales of Vir-7831 in Greater China From Low Single Digits to Low Double Digits.
Further Company Coverage: 2269.
Hk.
((reuters.
Briefs@thomsonreuters.
Com;)).